RDUS up +6.09% percent right now. $RDUS High is at 22.25 and the Low 20.55 with current volume of 99,300.
Recent News posted below.
RDUS Radius Health Inc. Recent Headline News
Radius Health Appoints Industry Veteran Dr. Willard Dere to Board of Directors
GlobeNewswire - Mon Nov 03, 7:37AM CST
Radius Health, Inc. (Nasdaq:RDUS) announced today the appointment of Dr. Willard H. Dere, to its Board of Directors. Dr. Dere was formerly at Amgen, where he led the development program of Prolia.
RDUS: 22.14 (+1.27)
Radius Health to Present at the 2014 BIO-Europe International Partnering Conference
GlobeNewswire - Tue Oct 28, 2:07PM CDT
Radius Health, Inc. (Nasdaq:RDUS) announced today that its Vice President, Business Development & Strategy, Geoffrey A. Swire, will present at the BIO-Europe Conference on Wednesday, November 5, 2014 at 12:45 p.m. Central European Time at the Portalhaus Messe Frankfurt, in Frankfurt, Germany.
RDUS: 22.14 (+1.27)
Biotech Offerings Fuel Health Care IPO Dominance
at Investor's Business Daily - Fri Oct 24, 3:41PM CDT
The health care sector leads the U.S. market for IPOs this year. It's the busiest year for IPOs in more than a decade. Health care has had 88 initial public offerings this year, primarily in the biotech sector. The No. 2 IPO sector is technology,...
RDUS: 22.14 (+1.27), GPRO: 79.06 (+0.30), CFG: 23.97 (-0.33), BABA: 114.56 (+2.99)
Radius Health Sponsors The Cancer Support Community "Elevating the Patient Voice" Symposium in Recognition of National Breast Cancer Awareness Month
GlobeNewswire - Thu Oct 23, 4:41PM CDT
Radius Health, Inc. (Nasdaq:RDUS) announced today it is a sponsor of The Cancer Support Community's symposium, "The Patient Voice: The First Year of the Cancer Experience Registry," in recognition of National Breast Cancer Awareness Month. Radius is pleased to help be a sponsor of this patient-focused event.
RDUS: 22.14 (+1.27)
Radius Health to Announce Third Quarter 2014 Financial Results, Host Conference Call and Live Webcast on Nov 11, 2014
GlobeNewswire - Tue Oct 21, 12:08PM CDT
Radius Health (Nasdaq:RDUS) announced today that it will release its third quarter 2014 financial results on Tuesday, November 11, 2014.
RDUS: 22.14 (+1.27)
Nasdaq stocks posting largest percentage decreases
AP - Tue Oct 14, 12:43PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
RDUS: 22.14 (+1.27), HTBX: 5.26 (-0.09), SFLY: 41.68 (+0.76), LAKE: 13.29 (+0.42), EXAC: 21.42 (-0.28), SNHY: 42.00 (-0.76), REXX: 8.00 (+0.50), MFNC: 10.78 (+0.05)
3 Stocks Spiking on Big Volume
at The Street - Thu Oct 09, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
RDUS: 22.14 (+1.27), ANET: 77.83 (-9.42), HAWK: 36.30 (+0.41)
Radius Health, Inc. Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire - Tue Oct 07, 1:29PM CDT
Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases, including hormone responsive cancers, today announced the closing of its previously announced public offering of 3,128,524 shares of common stock at a public offering price of $18.25 per share, including 378,524 shares sold pursuant to the partial exercise of the underwriters' option to purchase additional shares of common stock. The net proceeds from the offering, including the shares issued pursuant to the partial exercise of the underwriters' option to purchase additional shares, are expected to be approximately $53.3 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by Radius Health.
RDUS: 22.14 (+1.27)
Radius Health, Inc. Announces Pricing of Public Offering
GlobeNewswire - Thu Oct 02, 7:39AM CDT
Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases, including hormone responsive cancers, announced today that it has priced its public offering of 2,750,000 shares of its common stock at a public offering price of $18.25 per share. In addition, Radius Health has granted the underwriters a 30-day option to purchase up to an additional 412,500 shares of common stock.
RDUS: 22.14 (+1.27)
Radius Health, Inc. Announces Proposed Public Offering
GlobeNewswire - Wed Oct 01, 3:01PM CDT
Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases, including hormone responsive cancers, today announced that it is commencing an underwritten registered public offering of shares of its common stock.
RDUS: 22.14 (+1.27)
Radius Health (RDUS) Jumps: Stock Moves 13.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 8:25AM CDT
Radius Health (RDUS) was a big mover last session, with shares rising nearly 14% on the day.
RDUS: 22.14 (+1.27), ENDP: 68.96 (-1.23), LCI: 50.17 (-0.82), HPTX: 21.82 (-1.83)
Radius Health to Present at BioCentury NewsMakers in the Biotech Industry Conference
GlobeNewswire - Thu Sep 25, 11:55AM CDT
-- Radius Health Summarizes Recent Presentations regarding its Investigational Drug Abaloparatide at the American Society for Bone and Mineral Research and for its Investigational Drug RAD1901 at the 4 Annual Brain Metastases Research and Emerging Therapy Conference
RDUS: 22.14 (+1.27)
Radius Health (RDUS) is in Overbought Territory: What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 11:40AM CDT
Radius Health (RDUS) is in Overbought Territory: What’s Next?
RDUS: 22.14 (+1.27)
Radius Health (RDUS) in Focus: Stock Surges 17.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 7:44AM CDT
Radius Health, Inc. (RDUS) was a big mover last session, as the company saw its shares jump over 17% on the day.
RDUS: 22.14 (+1.27), LCI: 50.17 (-0.82), ENDP: 68.96 (-1.23), HPTX: 21.82 (-1.83)
Nasdaq stocks posting largest volume increases
AP - Tue Sep 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
RDUS: 22.14 (+1.27), PSBH: 7.23 (+0.04), ALCS: 0.30 (+0.01), SIAL: 135.34 (unch), MSON: 11.80 (-2.44), VYFC: 13.40 (-0.07), WAYN: 12.75 (+0.10), RITT: 1.16 (-0.02), SLTC: 5.84 (-0.20), CJJD: 1.73 (+0.02), TATT: 7.25 (+0.05)
Recent News posted below.
RDUS Radius Health Inc. Recent Headline News
Radius Health Appoints Industry Veteran Dr. Willard Dere to Board of Directors
GlobeNewswire - Mon Nov 03, 7:37AM CST
Radius Health, Inc. (Nasdaq:RDUS) announced today the appointment of Dr. Willard H. Dere, to its Board of Directors. Dr. Dere was formerly at Amgen, where he led the development program of Prolia.
RDUS: 22.14 (+1.27)
Radius Health to Present at the 2014 BIO-Europe International Partnering Conference
GlobeNewswire - Tue Oct 28, 2:07PM CDT
Radius Health, Inc. (Nasdaq:RDUS) announced today that its Vice President, Business Development & Strategy, Geoffrey A. Swire, will present at the BIO-Europe Conference on Wednesday, November 5, 2014 at 12:45 p.m. Central European Time at the Portalhaus Messe Frankfurt, in Frankfurt, Germany.
RDUS: 22.14 (+1.27)
Biotech Offerings Fuel Health Care IPO Dominance
at Investor's Business Daily - Fri Oct 24, 3:41PM CDT
The health care sector leads the U.S. market for IPOs this year. It's the busiest year for IPOs in more than a decade. Health care has had 88 initial public offerings this year, primarily in the biotech sector. The No. 2 IPO sector is technology,...
RDUS: 22.14 (+1.27), GPRO: 79.06 (+0.30), CFG: 23.97 (-0.33), BABA: 114.56 (+2.99)
Radius Health Sponsors The Cancer Support Community "Elevating the Patient Voice" Symposium in Recognition of National Breast Cancer Awareness Month
GlobeNewswire - Thu Oct 23, 4:41PM CDT
Radius Health, Inc. (Nasdaq:RDUS) announced today it is a sponsor of The Cancer Support Community's symposium, "The Patient Voice: The First Year of the Cancer Experience Registry," in recognition of National Breast Cancer Awareness Month. Radius is pleased to help be a sponsor of this patient-focused event.
RDUS: 22.14 (+1.27)
Radius Health to Announce Third Quarter 2014 Financial Results, Host Conference Call and Live Webcast on Nov 11, 2014
GlobeNewswire - Tue Oct 21, 12:08PM CDT
Radius Health (Nasdaq:RDUS) announced today that it will release its third quarter 2014 financial results on Tuesday, November 11, 2014.
RDUS: 22.14 (+1.27)
Nasdaq stocks posting largest percentage decreases
AP - Tue Oct 14, 12:43PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
RDUS: 22.14 (+1.27), HTBX: 5.26 (-0.09), SFLY: 41.68 (+0.76), LAKE: 13.29 (+0.42), EXAC: 21.42 (-0.28), SNHY: 42.00 (-0.76), REXX: 8.00 (+0.50), MFNC: 10.78 (+0.05)
3 Stocks Spiking on Big Volume
at The Street - Thu Oct 09, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
RDUS: 22.14 (+1.27), ANET: 77.83 (-9.42), HAWK: 36.30 (+0.41)
Radius Health, Inc. Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire - Tue Oct 07, 1:29PM CDT
Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases, including hormone responsive cancers, today announced the closing of its previously announced public offering of 3,128,524 shares of common stock at a public offering price of $18.25 per share, including 378,524 shares sold pursuant to the partial exercise of the underwriters' option to purchase additional shares of common stock. The net proceeds from the offering, including the shares issued pursuant to the partial exercise of the underwriters' option to purchase additional shares, are expected to be approximately $53.3 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by Radius Health.
RDUS: 22.14 (+1.27)
Radius Health, Inc. Announces Pricing of Public Offering
GlobeNewswire - Thu Oct 02, 7:39AM CDT
Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases, including hormone responsive cancers, announced today that it has priced its public offering of 2,750,000 shares of its common stock at a public offering price of $18.25 per share. In addition, Radius Health has granted the underwriters a 30-day option to purchase up to an additional 412,500 shares of common stock.
RDUS: 22.14 (+1.27)
Radius Health, Inc. Announces Proposed Public Offering
GlobeNewswire - Wed Oct 01, 3:01PM CDT
Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases, including hormone responsive cancers, today announced that it is commencing an underwritten registered public offering of shares of its common stock.
RDUS: 22.14 (+1.27)
Radius Health (RDUS) Jumps: Stock Moves 13.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 8:25AM CDT
Radius Health (RDUS) was a big mover last session, with shares rising nearly 14% on the day.
RDUS: 22.14 (+1.27), ENDP: 68.96 (-1.23), LCI: 50.17 (-0.82), HPTX: 21.82 (-1.83)
Radius Health to Present at BioCentury NewsMakers in the Biotech Industry Conference
GlobeNewswire - Thu Sep 25, 11:55AM CDT
-- Radius Health Summarizes Recent Presentations regarding its Investigational Drug Abaloparatide at the American Society for Bone and Mineral Research and for its Investigational Drug RAD1901 at the 4 Annual Brain Metastases Research and Emerging Therapy Conference
RDUS: 22.14 (+1.27)
Radius Health (RDUS) is in Overbought Territory: What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 11:40AM CDT
Radius Health (RDUS) is in Overbought Territory: What’s Next?
RDUS: 22.14 (+1.27)
Radius Health (RDUS) in Focus: Stock Surges 17.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 7:44AM CDT
Radius Health, Inc. (RDUS) was a big mover last session, as the company saw its shares jump over 17% on the day.
RDUS: 22.14 (+1.27), LCI: 50.17 (-0.82), ENDP: 68.96 (-1.23), HPTX: 21.82 (-1.83)
Nasdaq stocks posting largest volume increases
AP - Tue Sep 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
RDUS: 22.14 (+1.27), PSBH: 7.23 (+0.04), ALCS: 0.30 (+0.01), SIAL: 135.34 (unch), MSON: 11.80 (-2.44), VYFC: 13.40 (-0.07), WAYN: 12.75 (+0.10), RITT: 1.16 (-0.02), SLTC: 5.84 (-0.20), CJJD: 1.73 (+0.02), TATT: 7.25 (+0.05)
